Aptargroup

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions and services for the prescription drug, consumer health care, injectables, active packaging, beauty, personal care, home care, and food and beverages. It operates through the following business segments: Beauty & Home, Pharma and Food & Beverage. The Beauty & Home segment primarily sells pumps, aerosol valves and accessories to the personal care and household markets and pumps and decorative components to the fragrance/cosmetic market. The Pharma segment supplies pumps and metered dose inhaler valves to the pharmaceutical market worldwide. The Food & Beverage segment sells dispensing and non-dispensing closures and, to a lesser degree, spray pumps and aerosol valves to the food and beverage markets. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Aptargroup (ATR) reports robust Q4 results and strategic realignment

Aptargroup's Q4 performance reflects strong core sales growth and profitability, driven by the pharma and beauty segments, despite regional challenges.
Realignment initiatives aim to optimize operations and enhance market position, with a focus on cost management and sustainable growth opportunities.
While facing challenges such as volume declines and increased expenses, Aptar remains poised for growth with a positive outlook for the year ahead.
The company's strategic focus on capital efficiencies, innovation, and sustainability underscores its commitment to long-term success and profitability.

Aptar reports solid Q1 growth driven by Pharma and Beauty demand

Aptar's Q1 performance reflects growth in key segments, with a positive outlook for Q2. Strategic focus on operational efficiencies and new product innovations positions the company for continued success.

Aptargroup (ATR) reports solid Q2 performance and optimistic growth outlook

Aptargroup's Q2 2023 performance showcased strength in core sales growth, robust segmental performance, and a focus on sustainability and shareholder value.
While facing challenges in certain operational areas, the company remains optimistic about future growth prospects and is committed to addressing hurdles effectively.
With a positive outlook for Q3 and a strategic focus on innovation and sustainability, Aptar is well-positioned to capitalize on growth opportunities and drive long-term value creation.

Aptargroup reports 2% sales growth in Q3 driven by Pharma success

Aptargroup's Q3 performance reflects solid sales growth and profitability, driven by strength in Pharma and fragrance technologies.
The company's emphasis on innovation, sustainability, and governance underscores its commitment to long-term success and stakeholder value.
Despite challenges in the Beauty segment, Aptar's strategic focus on growth opportunities and cost optimization positions it well for future success.

Aptargroup (ATR) reports solid Q4 earnings, eyes Asia expansion

Aptargroup's Q4 2023 performance reflects steady growth, strong margins, and strategic initiatives for future expansion. While facing challenges in certain segments, the company's focus on innovation and sustainability, along with successful partnerships, positions it well for continued growth. Shareholders benefited from over $104 million returned in 2023.

Aptargroup (ATR) reports robust Q1 results, eyes pharma growth opportunities

Aptargroup's Q1 performance reflects a balanced growth trajectory with strengths in sustainability recognition and product innovation. While challenges in the Beauty segment persist, opportunities in pharma growth and margin improvement are key focus areas for future success.

Aptargroup (ATR) reports solid Q2 results, eyes growth opportunities

Aptargroup's Q2 performance reflects resilience and strategic focus on core business segments amidst market challenges.
The company's financial strength, sustainability recognition, and leadership continuity position it well for future growth.
Challenges in injectables and Beauty segments underscore the need for targeted strategies and market adaptation.
Opportunities lie in innovation, market expansion, and leveraging sustainability efforts for competitive advantage.

Aptar reports robust Q3 performance driven by pharma and food

Aptar's Q3 2024 performance reflects solid core sales growth and increased EPS, driven by strong demand in pharma and food segments. Challenges in the Beauty segment were offset by growth in personal care and home care markets.
Key strengths include operational improvements, acquisitions in the Pharma segment, and recognition for corporate excellence. Aptar's focus on innovation and efficiency presents opportunities for future growth.
While facing challenges in the Beauty segment and CFO transition, Aptar remains optimistic about growth prospects in Pharma and Closures segments, emphasizing innovation and market opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: AptarGroup (ATR) Q1 Earnings Expected to Decline

AptarGroup (ATR) expects weaker current-quarter results due to negative impact of the coronavirus pandemic.

AptarGroup (ATR) Hurt by Cost Woes & Coronavirus Outbreak

AptarGroup (ATR) reported earnings 30 days ago. What's next for the stock?

Why Is AptarGroup (ATR) Down 19.5% Since Last Earnings Report?

AptarGroup, Inc. (ATR) CEO Stephan Tanda on Q4 2019 Results - Earnings Call Transcript

AptarGroup (ATR) fourth-quarter earnings decline year-over-year thanks to inventory reductions by customers in the personal care and beauty markets. This is likely to persist in the first quarter of 2020.

AptarGroup (ATR) Q4 Earnings Beat Estimates, Revenues Miss

AptarGroup (ATR) delivered earnings and revenue surprises of 1.27% and -0.97%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

AptarGroup (ATR) Beats Q4 Earnings Estimates

AptarGroup (ATR) has agreed to acquire Fusion Packaging, in line with its strategy to cater to demand for fast beauty solutions with differentiated design and decorative offerings

AptarGroup to Acquire Fusion Packaging, Grow in Beauty Markets

Earnings Preview: AptarGroup (ATR) Q4 Earnings Expected to Decline

AptarGroup (ATR) delivers better-than-anticipated top-line growth in Q3, driven by strong broad-based demand for drug delivery and food dispensing solutions.

AptarGroup (ATR) Earnings Miss, Revenues Meet Estimates in Q3

AptarGroup, Inc. (ATR) CEO Stephan Tanda on Q3 2019 Results - Earnings Call Transcript

AptarGroup (ATR) delivered earnings and revenue surprises of -2.11% and 0.26%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

AptarGroup (ATR) Lags Q3 Earnings Estimates

Caterpillar

PayPal

Cummins

Evercore

ServiceNow

Union Pacific

Ken Fisher  ( Trades ,  Portfolio ), the CEO and chief investment officer of Fisher Investments, bought shares of the following stocks in both the second and third quarters.

Ken Fisher Continues to Buy PayPal, Caterpillar and more

AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AptarGroup (ATR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

AptarGroup, Inc. (ATR) has signed an agreement to acquire 49% equity interest in three related BTY companies in China that is in sync with its strategy to grow in Asia.

AptarGroup (ATR) to Buy 49% Stake in BTY, Expand in Asia

AptarGroup's (ATR) ongoing business transformation plan, innovative product roll outs and focused on expanding business through acquisitions are likely to help it to grow further.

AptarGroup (ATR) Rises 24% YTD: What's Driving the Rally?

AptarGroup's (ATR) partnership with PureCycle backs its vision for a circular economy, where materials and products are recycled without being reduced to waste.

AptarGroup's Deal With PureCycle Offers Sustainable Packaging

AptarGroup's (ATR) partnership with TerraCycle on the Loop e-commerce platform supports its vision for circular economy where packaging is not reduced to waste.

AptarGroup's Deal With Loop Offers Durable Packaging Solution

AptarGroup (ATR) puts up a stellar top-line performance in Q2, aided by solid broad-based demand for drug delivery and food dispensing solutions.

AptarGroup (ATR) Earnings Trump Estimates in Q2, Up Y/Y

AptarGroup, Inc. (ATR) CEO Stephan Tanda on Q2 2019 Results - Earnings Call Transcript

The dispensing products company is still comfortable with its position despite weakness in its beauty and home segment.

AptarGroup Leans on Pharma, Food, and Beverage Growth

AptarGroup (ATR) possesses solid growth attributes, which could help it handily outperform the market.

Looking for a Growth Stock? 3 Reasons Why AptarGroup (ATR) is a Solid Choice

AptarGroup (ATR) delivered earnings and revenue surprises of 1.77% and -1.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

AptarGroup (ATR) Q2 Earnings Surpass Estimates

3 Reasons Why Growth Investors Shouldn't Overlook AptarGroup (ATR)

AptarGroup (ATR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why AptarGroup (ATR) Could Beat Earnings Estimates Again

The bullish case for packaging solutions company AptarGroup, Inc. is based on expectations for upside versus consensus, new market opportunities and its exposure to the pharmaceutical sector being "mispriced," according to Morgan Stanley.

News for Aptargroup Stock (ATR)